FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

108419004: Ondansetron hydrochloride (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
172953013 Ondansetron hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
600539010 Ondansetron hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
44211000188119 ondansétron chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
829531000172114 chlorhydrate d'ondansétron fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron hydrochloride Is a Product containing ondansetron (medicinal product) false Inferred relationship Some
Ondansetron hydrochloride Is a Ondansetron (substance) false Inferred relationship Some
Ondansetron hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. 5-HT3 receptor antagonist true Inferred relationship Some
Ondansetron hydrochloride Is a Tricyclic compound (substance) true Inferred relationship Some
Ondansetron hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Ondansetron (substance) true Inferred relationship Some
Ondansetron hydrochloride Is a 5-HT3 receptor antagonist true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Ondansetron hydrochloride 0.25% injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ondansetron hydrochloride Inferred relationship Some
Ondansetron hydrochloride 2mg/mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ondansetron hydrochloride Inferred relationship Some
Ondansetron hydrochloride 2mg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ondansetron hydrochloride Inferred relationship Some
Ondansetron hydrochloride 4mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ondansetron hydrochloride Inferred relationship Some
Ondansetron hydrochloride 4mg/5 mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ondansetron hydrochloride Inferred relationship Some
Ondansetron hydrochloride 24 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ondansetron hydrochloride Inferred relationship Some
Ondansetron hydrochloride 2mg/mL injection solution 2 mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ondansetron hydrochloride Inferred relationship Some
Ondansetron hydrochloride 2mg/mL injection solution 4 mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ondansetron hydrochloride Inferred relationship Some
Ondansetron (as ondansetron hydrochloride) 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ondansetron hydrochloride Inferred relationship Some
Ondansetron 8mg oromucosal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ondansetron hydrochloride Inferred relationship Some
Ondansetron (as ondansetron hydrochloride) 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ondansetron hydrochloride Inferred relationship Some 1
Ondansetron hydrochloride 24 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ondansetron hydrochloride Inferred relationship Some 1
Ondansetron hydrochloride 24 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ondansetron hydrochloride Inferred relationship Some 1
Ondansetron (as ondansetron hydrochloride) 4 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ondansetron hydrochloride Inferred relationship Some 1
Ondansetron hydrochloride 24 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ondansetron hydrochloride Inferred relationship Some 1
Ondansetron (as ondansetron hydrochloride) 800 microgram/mL oral solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ondansetron hydrochloride Inferred relationship Some 1
Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/2 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Ondansetron hydrochloride Inferred relationship Some 1
Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/4 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Ondansetron hydrochloride Inferred relationship Some 1
Ondansetron (as ondansetron hydrochloride) 2 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ondansetron hydrochloride Inferred relationship Some 1
Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ondansetron hydrochloride Inferred relationship Some 1
Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ondansetron hydrochloride Inferred relationship Some 1
Ondansetron (as ondansetron hydrochloride) 8 mg orodispersible tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ondansetron hydrochloride Inferred relationship Some 1
Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release orodispersible film (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ondansetron hydrochloride Inferred relationship Some 1
Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible film (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ondansetron hydrochloride Inferred relationship Some 1
Ondansetron hydrochloride dihydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Ondansetron hydrochloride Inferred relationship Some
Product containing precisely ondansetron (as ondansetron hydrochloride) 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ondansetron hydrochloride Inferred relationship Some 1
Ondansetron hydrochloride anhydrous This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Ondansetron hydrochloride Inferred relationship Some

This concept is not in any reference sets

Back to Start